Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 5803031, 11 pages
http://dx.doi.org/10.1155/2016/5803031
Research Article

1H NMR-Based Analysis of Serum Metabolites in Monocrotaline-Induced Pulmonary Arterial Hypertensive Rats

1Fujian Hypertension Research Institute, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China
2MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, Key Laboratory for Chemical Biology of Fujian Province, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China
3The Physical Education Department, Xiamen University of Technology, Xiamen 361024, China

Received 6 October 2015; Accepted 7 December 2015

Academic Editor: Giuseppe Murdaca

Copyright © 2016 Taijie Lin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. J. Rubin, “Primary pulmonary hypertension,” The New England Journal of Medicine, vol. 336, no. 2, pp. 111–117, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. K. H. Cheever, “An overview of pulmonary arterial hypertension: risks, pathogenesis, clinical manifestations, and management,” The Journal of Cardiovascular Nursing, vol. 20, no. 2, pp. 108–118, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Sutendra and E. D. Michelakis, “Pulmonary arterial hypertension: challenges in translational research and a vision for change,” Science Translational Medicine, vol. 5, Article ID 208sr5, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. C. D. Cool, S. D. Groshong, J. Oakey, and N. F. Voelkel, “Pulmonary hypertension: cellular and molecular mechanisms,” Chest Journal, vol. 128, pp. 565S–571S, 2005. View at Google Scholar
  5. L. J. Rubin, “Metabolic dysfunction in the pathogenesis of pulmonary hypertension,” Cell Metabolism, vol. 12, no. 4, pp. 313–314, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. N. F. Voelkel, H. J. Bogaard, A. Al Husseini, L. Farkas, J. Gomez-Arroyo, and R. Natarajan, “Antioxidants for the treatment of patients with severe angioproliferative pulmonary hypertension?” Antioxidants and Redox Signaling, vol. 18, no. 14, pp. 1810–1817, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. D. I. Ellis, W. B. Dunn, J. L. Griffin, J. W. Allwood, and R. Goodacre, “Metabolic fingerprinting as a diagnostic tool,” Pharmacogenomics, vol. 8, no. 9, pp. 1243–1266, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. C. Lindon, E. Holmes, and J. K. Nicholson, “Metabonomics and its role in drug development and disease diagnosis,” Expert Review of Molecular Diagnostics, vol. 4, no. 2, pp. 189–199, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. J. L. Spratlin, N. J. Serkova, and S. G. Eckhardt, “Clinical applications of metabolomics in oncology: a review,” Clinical Cancer Research, vol. 15, no. 2, pp. 431–440, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Dutta, M. Joshi, S. Srivastava, I. Lodh, B. Chakravarty, and K. Chaudhury, “A metabonomics approach as a means for identification of potential biomarkers for early diagnosis of endometriosis,” Molecular BioSystems, vol. 8, no. 12, pp. 3281–3287, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. Q. Zhang, G. Wang, J. A et al., “Metabonomic profiling of diet-induced hyperlipidaemia in a rat model,” Biomarkers, vol. 15, no. 3, pp. 205–216, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. J. T. Brindle, J. K. Nicholson, P. M. Schofield, D. J. Grainger, and E. Holmes, “Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension,” Analyst, vol. 128, no. 1, pp. 32–36, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Luo, T. Lin, S. Zheng et al., “Adipose-derived stem cells attenuate pulmonary arterial hypertension and ameliorate pulmonary arterial remodeling in monocrotaline-induced pulmonary hypertensive rats,” Clinical and Experimental Hypertension, vol. 37, no. 3, pp. 241–248, 2014. View at Publisher · View at Google Scholar
  14. L. Xie, P. Lin, H. Xie, and C. Xu, “Effects of atorvastatin and losartan on monocrotaline-induced pulmonary artery remodeling in rats,” Clinical and Experimental Hypertension, vol. 32, no. 8, pp. 547–554, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Liang, H. Li, S. Zheng et al., “Comparison of early and delayed transplantation of adipose tissue-derived mesenchymal stem cells on pulmonary arterial function in monocrotaline-induced pulmonary arterial hypertensive rats,” European Heart Journal Supplements, vol. 17, supplement, pp. F4–F12, 2015. View at Publisher · View at Google Scholar
  16. K. R. Stenmark, B. Meyrick, N. Galie, W. J. Mooi, and I. F. McMurtry, “Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 297, no. 6, pp. L1013–L1032, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Liu, X. Xue, L. Gong et al., “1H NMR-based metabolomic analysis of triptolide-induced toxicity in liver-specific cytochrome P450 reductase knockout mice,” Metabolomics, vol. 8, no. 5, pp. 907–918, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Shao, J. Gu, C. Huang et al., “Malignancy-associated metabolic profiling of human glioma cell lines using 1H NMR spectroscopy,” Molecular Cancer, vol. 13, article 197, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. O. Beckonert, H. C. Keun, T. M. D. Ebbels et al., “Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts,” Nature protocols, vol. 2, no. 11, pp. 2692–2703, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Pérez-Enciso and M. Tenenhaus, “Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach,” Human Genetics, vol. 112, no. 5-6, pp. 581–592, 2003. View at Google Scholar · View at Scopus
  21. K. A. Cottrill and S. Y. Chan, “Metabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effect,” European Journal of Clinical Investigation, vol. 43, no. 8, pp. 855–865, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Ohira, R. deKemp, E. Pena et al., “Shifts in myocardial fatty acid and glucose metabolism in pulmonary arterial hypertension: a potential mechanism for a maladaptive right ventricular response,” European Heart Journal—Cardiovascular Imaging, 2015. View at Publisher · View at Google Scholar
  23. R. Rafikov, X. Sun, O. Rafikova et al., “Complex I dysfunction underlies the glycolytic switch in pulmonary hypertensive smooth muscle cells,” Redox Biology, vol. 6, pp. 278–286, 2015. View at Publisher · View at Google Scholar
  24. Y. Hoshikawa, S. Ono, S. Suzuki et al., “Generation of oxidative stress contributes to the development of hypertension by hypoxia,” Journal of Applied Physiology (1985), vol. 90, no. 4, pp. 1299–1306, 2001. View at Google Scholar
  25. Y. Zhao, J. Peng, C. Lu et al., “Metabolomic heterogeneity of pulmonary arterial hypertension,” PLoS ONE, vol. 9, no. 2, Article ID e88727, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. M.-C. Chaumais, B. Ranchoux, D. Montani et al., “N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats,” Respiratory Research, vol. 15, no. 1, article 65, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. V. Lachmanová, O. Hniličková, V. Povýšilová, V. Hampl, and J. Herget, “N-acetylcysteine inhibits hypoxic pulmonary hypertension most effectively in the initial phase of chronic hypoxia,” Life Sciences, vol. 77, no. 2, pp. 175–182, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Hue and H. Taegtmeyer, “The Randle cycle revisited: a new head for an old hat,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 297, no. 3, pp. E578–E591, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Oikawa, Y. Kagaya, H. Otani et al., “Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol,” Journal of the American College of Cardiology, vol. 45, no. 11, pp. 1849–1855, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Marsboom, C. Wietholt, C. R. Haney et al., “Lung 18F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension,” American Journal of Respiratory and Critical Care Medicine, vol. 185, no. 6, pp. 670–679, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Li, H. Tu, Y. Wang, and M. Levine, “Vitamin C in mouse and human red blood cells: an HPLC assay,” Analytical Biochemistry, vol. 426, no. 2, pp. 109–117, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Humbert, N. W. Morrell, S. L. Archer et al., “Cellular and molecular pathobiology of pulmonary arterial hypertension,” Journal of the American College of Cardiology, vol. 43, supplement, no. 12, pp. S13–S24, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. R. M. Tuder, L. A. Davis, and B. B. Graham, “Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension,” American Journal of Respiratory and Critical Care Medicine, vol. 185, no. 3, pp. 260–266, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. M. G. Vander Heiden, L. C. Cantley, and C. B. Thompson, “Understanding the warburg effect: the metabolic requirements of cell proliferation,” Science, vol. 324, no. 5930, pp. 1029–1033, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Selhub and J. W. Miller, “The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine,” The American Journal of Clinical Nutrition, vol. 55, no. 1, pp. 131–138, 1992. View at Google Scholar · View at Scopus
  36. S. H. Zeisel, “Metabolic crosstalk between choline/1-carbon metabolism and energy homeostasis,” Clinical Chemistry and Laboratory Medicine, vol. 51, no. 3, pp. 467–475, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. J. M. Mato and S. C. Lu, “The hepatocarcinogenic effect of methionine and choline deficient diets: an adaptation to the Warburg effect?” Alcoholism: Clinical and Experimental Research, vol. 35, no. 5, pp. 811–814, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. N. F. Voelkel, C. Cool, S. D. Lee, L. Wright, M. W. Geraci, and R. M. Tuder, “Primary pulmonary hypertension between inflammation and cancer,” Chest, vol. 114, no. 3, supplement, pp. 225S–230S, 1998. View at Publisher · View at Google Scholar
  39. P. R. Rai, C. D. Cool, J. A. C. King et al., “The cancer paradigm of severe pulmonary arterial hypertension,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 6, pp. 558–564, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. E. O. Agbani, P. Coats, A. Mills, and R. M. Wadsworth, “Peroxynitrite stimulates pulmonary artery endothelial and smooth muscle cell proliferation: involvement of ERK and PKC,” Pulmonary Pharmacology and Therapeutics, vol. 24, no. 1, pp. 100–109, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Sutendra, S. Bonnet, G. Rochefort et al., “Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodeling of pulmonary hypertension,” Science Translational Medicine, vol. 2, no. 44, Article ID 44ra58, 2010. View at Publisher · View at Google Scholar · View at Scopus